Massimo Fiorilli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot Study	BIOMEDICINES	2023
Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia	FRONTIERS IN IMMUNOLOGY	2023
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2	EARD	2022
A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disorders	GENES AND IMMUNITY	2020
Rheumatoid factor-producing CD21low anergic clonal B-cells in essential mixed cryoglobulinaemia: a model for autoantigen-driven pathogenesis of infectious and non-infectious cryoglobulinaemias	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2020
Clinico-immunologic outcomes of HCV-cured cryoglobulinemia: lower relapse rate with interferon-based than interferon-free therapy	LIVER INTERNATIONAL	2020
Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis.	LIVER INTERNATIONAL	2019
Long term outcome of WHIM syndrome in 18 patients: high risk of lung disease and HPV-related malignancies.	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. IN PRACTICE	2019
The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: insights from EVA study	FRONTIERS IN ENDOCRINOLOGY	2019
Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer	RHEUMATOLOGY	2018
DEC1/STRA13 is a key negative regulator of activation-induced proliferation of human B cells highly expressed in anergic cells	IMMUNOLOGY LETTERS	2018
Persistence of pathogenic B cell clones and relapse of cryoglobulinemic vasculitis in HCV-cured patients	GASTROENTEROLOGY	2018
Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis	CLINICAL RHEUMATOLOGY	2017
Reversion of anergy signatures in clonal CD21low B cells of mixed cryoglobulinemia after clearance of HCV viremia.	BLOOD	2017
From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?	EXPERT REVIEW OF HEMATOLOGY	2017
Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY	2016
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia	HEPATOLOGY	2016
The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti-hepatitis C virus therapy.	HEPATOLOGY	2015
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review	AUTOIMMUNITY REVIEWS	2015